Viridian Therapeutics Inc
Biotechnology
Healthcare
VRDN
81.34 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
19.45
52 week high
25.71
high
19.84
52 week low
0.00
low
19.00
growth
-12.29 %
previous Close
19.55
P/E ratio
market cap
1.28 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
120711.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top